Opin vísindi

STOPP/START criteria for potentially inappropriate prescribing in older people : version 3

STOPP/START criteria for potentially inappropriate prescribing in older people : version 3


Titill: STOPP/START criteria for potentially inappropriate prescribing in older people : version 3
Höfundur: O'Mahony, Denis
Cherubini, Antonio
Guiteras, Anna Renom
Denkinger, Michael
Beuscart, Jean-Baptiste
Onder, Graziano
Guðmundsson, Aðalsteinn
Cruz-Jentoft, Alfonso J
Knol, Wilma
Bahat, Gülistan
... 3 fleiri höfundar Sýna alla höfunda
Útgáfa: 2023-08
Tungumál: Enska
Umfang: 8
Deild: Other departments
Birtist í: European Geriatric Medicine; 14(4)
ISSN: 1878-7649
DOI: 10.1007/s41999-023-00777-y
Efnisorð: Öldrunarlæknisfræði; Adverse drug events; Medication review; Multimorbidity; Older people; Polypharmacy; STOPP/START criteria; Potentially Inappropriate Medication List; Europe; Humans; Drug Prescriptions; Practice Patterns, Physicians'; Aged; Inappropriate Prescribing/prevention & control; Geriatrics and Gerontology; Gerontology
URI: https://hdl.handle.net/20.500.11815/4251

Skoða fulla færslu

Tilvitnun:

O'Mahony , D , Cherubini , A , Guiteras , A R , Denkinger , M , Beuscart , J-B , Onder , G , Guðmundsson , A , Cruz-Jentoft , A J , Knol , W , Bahat , G , van der Velde , N , Petrovic , M & Curtin , D 2023 , ' STOPP/START criteria for potentially inappropriate prescribing in older people : version 3 ' , European Geriatric Medicine , vol. 14 , no. 4 , pp. 625-632 . https://doi.org/10.1007/s41999-023-00777-y

Útdráttur:

PURPOSE: STOPP/START is a physiological systems-based explicit set of criteria that attempts to define the clinically important prescribing problems relating to potentially inappropriate medications (PIMs-STOPP criteria) and potential prescribing omissions (PPOs-START criteria). The previous two versions of STOPP/START criteria were published in 2008 and 2015. The present study describes the revised and updated third version of the criteria. METHODS: A detailed system-by-system review of the published literature from April 2014 to March 2022 was undertaken with the aim of including clinically important new explicit PIM and PPO criteria and removing any criteria considered to be no longer correct or outdated. A panel of 11 academic physicians with recognized expertise in geriatric pharmacotherapy from 8 European countries participated in a Delphi panel with the task of validating the draft criteria. The panel was presented with the draft new criteria using the SurveyMonkey® on-line platform in which panelists were asked to indicate their level of agreement on a five-point Likert scale. RESULTS: Two hundred and four evidence-based draft criteria (one hundred and forty-five STOPP criteria, fifty-nine START criteria) were presented to panelists for assessment using the Delphi validation method. Over the course of four rounds of Delphi validation, the panel achieved consensus on 133 STOPP criteria and 57 START criteria, i.e., 190 STOPP/START criteria in total representing a 66.7% increase in the number of criteria compared to STOPP/START version 2 published in 2015. CONCLUSION: A fully revised and updated version of STOPP/START criteria has been validated by a European expert panel using the Delphi consensus process.

Athugasemdir:

Publisher Copyright: © 2023, The Author(s).

Skrár

Þetta verk birtist í eftirfarandi safni/söfnum: